Haleon is teaming up with the University of Sydney to launch a five-year fellowship to research the efficacy of dietary supplements for ...

Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been ...

Skyrizi had an estimated national TV ad spend of $93.7 million — the highest amount of any brand in the top 10 during this ...

The mRNA-based supplier of vaccines profited from Covid-19 vaccine sales. As the years passed, Covid evolved. The weaker ...

The major European markets closed higher higher on Monday as largely firm Asian markets and the recent upbeat jobs data from the U.S. helped keep investor sentiment ...

The idea is that if you move your focus to attracting people, you’ll ultimately attract the companies: If you build it (the ...

Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...

Pfizer Inc. (NYSE: PFE) hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE (NASDAQ: BNTX) ...

Activist investor Starboard Value has taken a stake of about US$1 billion in Pfizer and is seeking to spur a turnaround of ...

London’s FTSE 100 was up 0.3% at 8,303.60 in afternoon trade on Monday. Shell and BP were among the top gainers as oil prices ...

Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...

Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Pfizer (PFE – Research Report). The associated price target ...